Hope for Malaria Vaccine by 2015

British drug maker GlaxoSmithKline is seeking regulatory approval for the world’s first malaria vaccine after trial data showed that it had cut the number of cases in African children. Experts say that they are optimistic about the possibility of the world’s first vaccine after the trial results. Malaria, a mosquito-borne parasitic disease, kills hundreds of… Continue reading Hope for Malaria Vaccine by 2015

Malaria Vaccine Shows Early Promise in Clinical Trials

By Rebecca Morelle, BBC Science A malaria vaccine has shown promising results in early stage clinical trials, according to researchers. Researchers found the vaccine, which is being developed in the US, protected 12 out of 15 patients from the disease, when given in high doses. The method is unusual because it involves injecting live but… Continue reading Malaria Vaccine Shows Early Promise in Clinical Trials

Malaria Vaccine: Now A Possibility

GlaxoSmithKline research head Moncef Slaoui explains how change of focus to cellular immunity was key to breakthrough Moncef Slaoui was on holiday with his family when he heard the results of the first small trial, involving African infants, of the malaria vaccine he helped invent. It was a day he would never forget. “It was… Continue reading Malaria Vaccine: Now A Possibility

Malaria Deaths Fall over 20% Worldwide in Last Decade

There has been a fall of just over 20% in the number of deaths from malaria worldwide in the past decade, the World Health Organization says. A new report said that one-third of the 108 countries where malaria was endemic were on course to eradicate the disease within 10 years. Experts said if targets continued… Continue reading Malaria Deaths Fall over 20% Worldwide in Last Decade

GlaxoSmithKline Malaria Vaccine Tests Show Hopeful Results

The quest for the world’s first malaria vaccine appears to have taken a big step: A study in Africa shows experimental shots cut the risk of disease in young children by half.

The initial results from a final stage of vaccine testing were released Tuesday, and the vaccine’s developers called it a milestone in helping to tame one of the world’s most devastating killers

Malaria Vaccine Trial Raises Hope

Researchers are to expand a clinical trial of a new malaria vaccine after promising results in a preliminary study in Burkina Faso.

The trial was designed to test safety, but researchers found that vaccinated children had high levels of protection.
Around a hundred different malaria vaccine candidates have been developed to date but the MSP3 vaccine tested in Burkina Faso is only the second one to show a substantial level of protection against the illness.

Drug Firms Cut Vaccine Prices to the Developing World

Several major drugs companies have announced big cuts to the amounts they charge for their vaccines in the developing world. GlaxoSmithKline (GSK), Merck, Johnson & Johnson and Sanofi-Aventis have agreed to cut prices through the international vaccine alliance Gavi. GSK said it would cut the price of its vaccine for rotavirus by 67% to $2.50… Continue reading Drug Firms Cut Vaccine Prices to the Developing World

Generic Malaria Drug Approval Granted to Glenmark Pharmaceuticals

The United States Food and Drug Administration (FDA) has granted Glenmark Pharmaceuticals final approval to sell a generic version of GlaxoSmithKline (GSK) malaria drug Malarone. In April 2010, Glenmark settled a patent litigation with GlaxoSmithKline over atovaquone and proguanil hydrochloride 250 milligram/100mg tablets–the generic version of Malarone. The Indian company can sell the generic tablets… Continue reading Generic Malaria Drug Approval Granted to Glenmark Pharmaceuticals